MedPath
HSA Approval

VARADIN FILM-COATED TABLETS 7.5MG

SIN17220P

VARADIN FILM-COATED TABLETS 7.5MG

VARADIN FILM-COATED TABLETS 7.5MG

April 22, 2025

PHARMAKOE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAKOE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C01EB17

Manufacturer Information

PHARMAKOE PTE. LTD.

GENEPHARM S.A

Active Ingredients

Ivabradine hydrochloride eqv Ivabradine

7.5 mg

Ivabradine

Documents

Package Inserts

Varadin Tablet PI.pdf

Approved: April 22, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VARADIN FILM-COATED TABLETS 7.5MG - HSA Approval | MedPath